Johns Hopkins scientists raise $137M megaround for a trio of spinouts looking to tackle Alzheimer’s, Parkinson’s and fibrosis
A US/Korean hybrid biotech run by a group of scientists out of Johns Hopkins just scored a megaround of $137.1 million, with plans to advance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
